# Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate

> **NCT04361175** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 212 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Clomiphine Citrate

## Key facts

- **NCT ID:** NCT04361175
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361175, "Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04361175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*